Document Detail

Antidepressant combinations: widely used, but far from empirically validated.
MedLine Citation:
PMID:  21756445     Owner:  NLM     Status:  In-Data-Review    
This paper reviews the evidence on combining antidepressants (ADs) for treatment of major depressive disorder. Although widely used and usually safe, the efficacy of even the most widely prescribed combinations of ADs has not been established by properly controlled, adequately powered, clinical trials. This stands in contrast to several adjunctive strategies for AD nonresponders, including adjunctive lithium, thyroid hormone, or newer-generation antipsychotics. The wide use of AD combinations no doubt reflects the limited efficacy of commonly used ADs and the unmet need for effective strategies for patients with treatment-resistant depression. Although of unproven efficacy, potential merits of combining selected ADs include: 1) avoiding discontinuation-emergent symptoms and cross-titration schedules, 2) at worst, the second AD should be as effective in combination as it would be as a monotherapy following a switch, and 3) the possibility of complementary neuropharmacologic effects that may enhance efficacy or improve tolerability. The dearth of controlled studies of such a commonly used strategy for such a highly prevalent condition is symptomatic of shortcomings in the way clinically relevant research is funded, points to the need for industry-academic-federal collaborations, and underscores the need for large, practice-based, research groups that can efficiently complete publicly funded studies of high public health impact.
Michael E Thase
Related Documents :
20561315 - Measuring patient anxiety in primary care: rasch analysis of the 6-item spielberger sta...
2086545 - The ketterer stress symptom frequency checklist: anger and the severity of coronary art...
19134505 - Psychological reactions to amputation in a sample of nigerian amputees.
12858145 - Neurobiology and mechanisms of antidepressant treatment response in anxiety.
22555225 - The impact of beta-blockers on mortality in stable angina: a meta-analysis.
22709365 - Scores on the mmpi-2-rf scales as a function of increasing levels of failure on cogniti...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Canadian journal of psychiatry. Revue canadienne de psychiatrie     Volume:  56     ISSN:  1497-0015     ISO Abbreviation:  Can J Psychiatry     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-07-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7904187     Medline TA:  Can J Psychiatry     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  317-23     Citation Subset:  IM    
Professor of Psychiatry, University of Pennsylvania School of Medicine and Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania; Adjunct Professor of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Early adversity and adult health outcomes.
Next Document:  Winning and losing: an evolutionary approach to mood disorders and their therapy.